Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M262Revenue $M10.3Net Margin (%)38.6Z-Score20.5
Enterprise Value $M223EPS $-0.6Operating Margin %28.0F-Score5
P/E(ttm))26.4Cash Flow Per Share $1.4Pre-tax Margin (%)38.6Higher ROA y-yY
Price/Book6.810-y EBITDA Growth Rate %0Quick Ratio6.2Cash flow > EarningsN
Price/Sales9.75-y EBITDA Growth Rate %0Current Ratio6.2Lower Leverage y-yY
Price/Cash Flow3.6y-y EBITDA Growth Rate %0ROA % (ttm)21.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)29.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M32.1ROI % (ttm)-25.4Gross Margin Increase y-yN

Gurus Latest Trades with POZN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
POZNJohn Rogers 2014-06-30 Reduce-0.12%$7.69 - $9.6
($8.6)
$ 7.9-8%Reduce -41.14%1,813,164
POZNJohn Rogers 2013-12-31 Reduce-0.07%$5.58 - $9.77
($7.13)
$ 7.911%Reduce -20.01%3,503,586
POZNJohn Rogers 2013-09-30 Add0.1%$5 - $5.92
($5.53)
$ 7.943%Add 35.67%4,379,824
POZNJohn Rogers 2013-06-30 Add0.2%$4.5 - $5.5
($4.99)
$ 7.958%Add 311.99%3,228,236
POZNJohn Rogers 2013-03-31 Buy 0.07%$5.01 - $6.41
($5.72)
$ 7.938%New holding, 783580 sh.783,580
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

POZN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
POZN John Rogers 2014-09-302,071,9206.460.2+14.27%
Premium Most recent portfolio changes are included for Premium Members only!


POZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAR INVESTMENT PARTNERS LP10% Owner 2014-12-01Buy500,000$7.58view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-11-18Sell50,000$9-10view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-11-06Sell50,000$9.08-10.79view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-10-21Sell50,000$8.17-0.86view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-10-09Sell50,000$8.12-0.25view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-09-30Sell50,000$7.488.29view
McNamara Dennis LEVP, Chief Business Officer 2014-09-15Sell4,275$7.853.18view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-09-09Sell50,000$8.24-1.7view
BARNHARDT JOHN EVP, Finance and Administration 2014-08-25Sell4,293$8.25-1.82view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-08-20Sell50,000$7.784.11view

Press Releases about POZN :

    Quarterly/Annual Reports about POZN:

    News about POZN:

    Articles On GuruFocus.com
    Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of A Oct 15 2014 
    Weekly Insider Sells Highlight: AR, CSCO, SUTR, POZN, JAH May 27 2014 
    Guru Weekly Real Time Update Jul 12 2013 
    John Rogers Makes 5 Real-Time Increases Jul 11 2013 
    John Rogers' May Commentary - What's Attractive and New Buys Jun 13 2013 
    comment on POZN Nov 13 2012 
    Pozen Inc. Reports Operating Results (10-K) Mar 10 2011 
    Pozen Inc. Reports Operating Results (10-Q) Oct 29 2010 
    Pozen Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Pozen Inc. Reports Operating Results (10-Q) Apr 29 2010 

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK